Cornercap Investment Counsel Inc Tenaya Therapeutics, Inc. Call Options Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TNYA
# of Institutions
90Shares Held
47.2MCall Options Held
35.8KPut Options Held
1.1K-
Column Group LLC San Francisco, CA9.4MShares$28 Million30.64% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$20.1 Million2.84% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$14 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.35MShares$9.97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.86MShares$8.53 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $123M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...